Coronary artery changes in patients with Kawasaki disease
Kawasaki disease (KD) is an acute, self‐limiting, systemic vasculitis of unknown aetiology, which most commonly occurs in children aged 6 mo to 5 y, with a peak incidence at 9–11 mo. The inflammatory process preferentially involves the coronary arteries, potentially resulting in coronary arteritis,...
Gespeichert in:
Veröffentlicht in: | Acta Paediatrica 2004-11, Vol.93 (s446), p.75-79 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 79 |
---|---|
container_issue | s446 |
container_start_page | 75 |
container_title | Acta Paediatrica |
container_volume | 93 |
creator | Tulloh, RMR Wood, LE |
description | Kawasaki disease (KD) is an acute, self‐limiting, systemic vasculitis of unknown aetiology, which most commonly occurs in children aged 6 mo to 5 y, with a peak incidence at 9–11 mo. The inflammatory process preferentially involves the coronary arteries, potentially resulting in coronary arteritis, aneurysmal lesions, arterial thrombotic occlusion and sudden death. Kawasaki disease is the most common cause of acquired coronary vessel abnormalities in children. The cause of KD is not known, but evidence is presented for an inflammatory response and a genetic predisposition. The diagnostic tests are not yet defined, but treatment with immunoglobulin and aspirin is effective at reducing the risk of cardiac complications from 25% to 4.7% in the UK. Sequelae may occur, either acutely with myocardial, endocardial or pericardial inflammation, or many years after the original illness. There may be abnormalities of myocardial blood flow as assessed by MRI, radio‐nucleide studies or echo Doppler. Such abnormalities of coronary arteries may require ongoing medication, interventional catheterization or even cardiac surgery.
Conclusion: In the future, we hope to have more accurate diagnostic tests or prophylaxis against the disease, in addition to improved means of determining the susceptibility to or presence of long‐term complications. |
doi_str_mv | 10.1111/j.1651-2227.2004.tb00243.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67244935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67244935</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2845-a8edbb7587db510f54a49b6f003c2d60e12f4e4d0ce63139688aecf1bcb477773</originalsourceid><addsrcrecordid>eNqVkM1u1DAURi0EokPhFVCEBLsE_ztBYjGMaIsYCgsQS-vGuaGeZpKpndFM376OJmrX3M1d-Hy2v0PIO0YLlubjpmBasZxzbgpOqSzGmlIuRXF8RhaPR8_JgpZU5IorcUZexbhJkKikfknOmDKUayMXpFoNYegh3GcQRkzL3UD_D2Pm-2wHo8d-jNnBjzfZdzhAhFufNT4iRHxNXrTQRXwz73Py5-Lr79VVvv55-W21XOeOl1LlUGJT10aVpqkVo62SIKtat5QKxxtNkfFWomyoQy2YqHRZArqW1a6WJo04Jx9O9-7CcLfHONqtjw67Dnoc9tFqw6WshErgpxPowhBjwNbugt-mapZRO4mzGzvZsZMdO4mzszh7TOG38yv7eovNU3Q2lYD3MwDRQdcG6J2PT5wWVcWoSNznE3fwHd7_xxfs8tfSTC3yU97HEY-PeQi3qakwyv69vrTrH9XVNVXCfhEPqNuYpg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67244935</pqid></control><display><type>article</type><title>Coronary artery changes in patients with Kawasaki disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Tulloh, RMR ; Wood, LE</creator><creatorcontrib>Tulloh, RMR ; Wood, LE</creatorcontrib><description>Kawasaki disease (KD) is an acute, self‐limiting, systemic vasculitis of unknown aetiology, which most commonly occurs in children aged 6 mo to 5 y, with a peak incidence at 9–11 mo. The inflammatory process preferentially involves the coronary arteries, potentially resulting in coronary arteritis, aneurysmal lesions, arterial thrombotic occlusion and sudden death. Kawasaki disease is the most common cause of acquired coronary vessel abnormalities in children. The cause of KD is not known, but evidence is presented for an inflammatory response and a genetic predisposition. The diagnostic tests are not yet defined, but treatment with immunoglobulin and aspirin is effective at reducing the risk of cardiac complications from 25% to 4.7% in the UK. Sequelae may occur, either acutely with myocardial, endocardial or pericardial inflammation, or many years after the original illness. There may be abnormalities of myocardial blood flow as assessed by MRI, radio‐nucleide studies or echo Doppler. Such abnormalities of coronary arteries may require ongoing medication, interventional catheterization or even cardiac surgery.
Conclusion: In the future, we hope to have more accurate diagnostic tests or prophylaxis against the disease, in addition to improved means of determining the susceptibility to or presence of long‐term complications.</description><identifier>ISSN: 0803-5253</identifier><identifier>ISSN: 0803-5326</identifier><identifier>EISSN: 1651-2227</identifier><identifier>DOI: 10.1111/j.1651-2227.2004.tb00243.x</identifier><identifier>PMID: 15702674</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aspirin ; Biological and medical sciences ; Child ; Child, Preschool ; coronary aneurysms ; Coronary Circulation - physiology ; Coronary Disease - diagnosis ; Coronary Disease - etiology ; Coronary Disease - prevention & control ; Coronary Vessels - pathology ; Coronary Vessels - physiopathology ; endothelial dysfunction ; Endothelium, Vascular - pathology ; Endothelium, Vascular - physiopathology ; Fundamental and applied biological sciences. Psychology ; Genetics of eukaryotes. Biological and molecular evolution ; Humans ; immunoglobulin ; Infant ; Medical genetics ; Medical sciences ; Molecular and cellular biology ; Mucocutaneous Lymph Node Syndrome - diagnosis ; Mucocutaneous Lymph Node Syndrome - pathology ; Mucocutaneous Lymph Node Syndrome - physiopathology ; Mucocutaneous Lymph Node Syndrome - therapy ; vasculitis</subject><ispartof>Acta Paediatrica, 2004-11, Vol.93 (s446), p.75-79</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2845-a8edbb7587db510f54a49b6f003c2d60e12f4e4d0ce63139688aecf1bcb477773</citedby><cites>FETCH-LOGICAL-c2845-a8edbb7587db510f54a49b6f003c2d60e12f4e4d0ce63139688aecf1bcb477773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1651-2227.2004.tb00243.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1651-2227.2004.tb00243.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,1411,23909,23910,25118,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16399103$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15702674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tulloh, RMR</creatorcontrib><creatorcontrib>Wood, LE</creatorcontrib><title>Coronary artery changes in patients with Kawasaki disease</title><title>Acta Paediatrica</title><addtitle>Acta Paediatr Suppl</addtitle><description>Kawasaki disease (KD) is an acute, self‐limiting, systemic vasculitis of unknown aetiology, which most commonly occurs in children aged 6 mo to 5 y, with a peak incidence at 9–11 mo. The inflammatory process preferentially involves the coronary arteries, potentially resulting in coronary arteritis, aneurysmal lesions, arterial thrombotic occlusion and sudden death. Kawasaki disease is the most common cause of acquired coronary vessel abnormalities in children. The cause of KD is not known, but evidence is presented for an inflammatory response and a genetic predisposition. The diagnostic tests are not yet defined, but treatment with immunoglobulin and aspirin is effective at reducing the risk of cardiac complications from 25% to 4.7% in the UK. Sequelae may occur, either acutely with myocardial, endocardial or pericardial inflammation, or many years after the original illness. There may be abnormalities of myocardial blood flow as assessed by MRI, radio‐nucleide studies or echo Doppler. Such abnormalities of coronary arteries may require ongoing medication, interventional catheterization or even cardiac surgery.
Conclusion: In the future, we hope to have more accurate diagnostic tests or prophylaxis against the disease, in addition to improved means of determining the susceptibility to or presence of long‐term complications.</description><subject>Aspirin</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>coronary aneurysms</subject><subject>Coronary Circulation - physiology</subject><subject>Coronary Disease - diagnosis</subject><subject>Coronary Disease - etiology</subject><subject>Coronary Disease - prevention & control</subject><subject>Coronary Vessels - pathology</subject><subject>Coronary Vessels - physiopathology</subject><subject>endothelial dysfunction</subject><subject>Endothelium, Vascular - pathology</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetics of eukaryotes. Biological and molecular evolution</subject><subject>Humans</subject><subject>immunoglobulin</subject><subject>Infant</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Molecular and cellular biology</subject><subject>Mucocutaneous Lymph Node Syndrome - diagnosis</subject><subject>Mucocutaneous Lymph Node Syndrome - pathology</subject><subject>Mucocutaneous Lymph Node Syndrome - physiopathology</subject><subject>Mucocutaneous Lymph Node Syndrome - therapy</subject><subject>vasculitis</subject><issn>0803-5253</issn><issn>0803-5326</issn><issn>1651-2227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkM1u1DAURi0EokPhFVCEBLsE_ztBYjGMaIsYCgsQS-vGuaGeZpKpndFM376OJmrX3M1d-Hy2v0PIO0YLlubjpmBasZxzbgpOqSzGmlIuRXF8RhaPR8_JgpZU5IorcUZexbhJkKikfknOmDKUayMXpFoNYegh3GcQRkzL3UD_D2Pm-2wHo8d-jNnBjzfZdzhAhFufNT4iRHxNXrTQRXwz73Py5-Lr79VVvv55-W21XOeOl1LlUGJT10aVpqkVo62SIKtat5QKxxtNkfFWomyoQy2YqHRZArqW1a6WJo04Jx9O9-7CcLfHONqtjw67Dnoc9tFqw6WshErgpxPowhBjwNbugt-mapZRO4mzGzvZsZMdO4mzszh7TOG38yv7eovNU3Q2lYD3MwDRQdcG6J2PT5wWVcWoSNznE3fwHd7_xxfs8tfSTC3yU97HEY-PeQi3qakwyv69vrTrH9XVNVXCfhEPqNuYpg</recordid><startdate>200411</startdate><enddate>200411</enddate><creator>Tulloh, RMR</creator><creator>Wood, LE</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200411</creationdate><title>Coronary artery changes in patients with Kawasaki disease</title><author>Tulloh, RMR ; Wood, LE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2845-a8edbb7587db510f54a49b6f003c2d60e12f4e4d0ce63139688aecf1bcb477773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aspirin</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>coronary aneurysms</topic><topic>Coronary Circulation - physiology</topic><topic>Coronary Disease - diagnosis</topic><topic>Coronary Disease - etiology</topic><topic>Coronary Disease - prevention & control</topic><topic>Coronary Vessels - pathology</topic><topic>Coronary Vessels - physiopathology</topic><topic>endothelial dysfunction</topic><topic>Endothelium, Vascular - pathology</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetics of eukaryotes. Biological and molecular evolution</topic><topic>Humans</topic><topic>immunoglobulin</topic><topic>Infant</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Molecular and cellular biology</topic><topic>Mucocutaneous Lymph Node Syndrome - diagnosis</topic><topic>Mucocutaneous Lymph Node Syndrome - pathology</topic><topic>Mucocutaneous Lymph Node Syndrome - physiopathology</topic><topic>Mucocutaneous Lymph Node Syndrome - therapy</topic><topic>vasculitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tulloh, RMR</creatorcontrib><creatorcontrib>Wood, LE</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta Paediatrica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tulloh, RMR</au><au>Wood, LE</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coronary artery changes in patients with Kawasaki disease</atitle><jtitle>Acta Paediatrica</jtitle><addtitle>Acta Paediatr Suppl</addtitle><date>2004-11</date><risdate>2004</risdate><volume>93</volume><issue>s446</issue><spage>75</spage><epage>79</epage><pages>75-79</pages><issn>0803-5253</issn><issn>0803-5326</issn><eissn>1651-2227</eissn><abstract>Kawasaki disease (KD) is an acute, self‐limiting, systemic vasculitis of unknown aetiology, which most commonly occurs in children aged 6 mo to 5 y, with a peak incidence at 9–11 mo. The inflammatory process preferentially involves the coronary arteries, potentially resulting in coronary arteritis, aneurysmal lesions, arterial thrombotic occlusion and sudden death. Kawasaki disease is the most common cause of acquired coronary vessel abnormalities in children. The cause of KD is not known, but evidence is presented for an inflammatory response and a genetic predisposition. The diagnostic tests are not yet defined, but treatment with immunoglobulin and aspirin is effective at reducing the risk of cardiac complications from 25% to 4.7% in the UK. Sequelae may occur, either acutely with myocardial, endocardial or pericardial inflammation, or many years after the original illness. There may be abnormalities of myocardial blood flow as assessed by MRI, radio‐nucleide studies or echo Doppler. Such abnormalities of coronary arteries may require ongoing medication, interventional catheterization or even cardiac surgery.
Conclusion: In the future, we hope to have more accurate diagnostic tests or prophylaxis against the disease, in addition to improved means of determining the susceptibility to or presence of long‐term complications.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>15702674</pmid><doi>10.1111/j.1651-2227.2004.tb00243.x</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0803-5253 |
ispartof | Acta Paediatrica, 2004-11, Vol.93 (s446), p.75-79 |
issn | 0803-5253 0803-5326 1651-2227 |
language | eng |
recordid | cdi_proquest_miscellaneous_67244935 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection |
subjects | Aspirin Biological and medical sciences Child Child, Preschool coronary aneurysms Coronary Circulation - physiology Coronary Disease - diagnosis Coronary Disease - etiology Coronary Disease - prevention & control Coronary Vessels - pathology Coronary Vessels - physiopathology endothelial dysfunction Endothelium, Vascular - pathology Endothelium, Vascular - physiopathology Fundamental and applied biological sciences. Psychology Genetics of eukaryotes. Biological and molecular evolution Humans immunoglobulin Infant Medical genetics Medical sciences Molecular and cellular biology Mucocutaneous Lymph Node Syndrome - diagnosis Mucocutaneous Lymph Node Syndrome - pathology Mucocutaneous Lymph Node Syndrome - physiopathology Mucocutaneous Lymph Node Syndrome - therapy vasculitis |
title | Coronary artery changes in patients with Kawasaki disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T23%3A30%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coronary%20artery%20changes%20in%20patients%20with%20Kawasaki%20disease&rft.jtitle=Acta%20Paediatrica&rft.au=Tulloh,%20RMR&rft.date=2004-11&rft.volume=93&rft.issue=s446&rft.spage=75&rft.epage=79&rft.pages=75-79&rft.issn=0803-5253&rft.eissn=1651-2227&rft_id=info:doi/10.1111/j.1651-2227.2004.tb00243.x&rft_dat=%3Cproquest_cross%3E67244935%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67244935&rft_id=info:pmid/15702674&rfr_iscdi=true |